| SAM | Non-SAM |  | ||
---|---|---|---|---|---|
 | n/Na | Kaplan–Meier estimate (95 % CI) | n/Na | Kaplan–Meier estimate (95 % CI) | P |
Day 28 PCR-corrected ACPRb | |||||
 mITT | 131/131 | 100 % (NA) | 263/266 | 98.9 % (96.5–99.6) | 0.232 |
 PP | 118/118 | 100 % (NA) | 241/244 | 98.9 % (96.2–99.6) | 0.227 |
Day 42 PCR-corrected ACPR | |||||
 mITT | 131/131 | 100 % (NA) | 262/266 | 98.3 % (95.6–99.4) | 0.168 |
 PP | 118/118 | 100 % (NA) | 240/244 | 98.2 % (95.3–99.3) | 0.162 |
Day 28 uncorrected ACPR | |||||
 mITT | 108/131 | 81.3 % (73.3–87.2) | 223/266 | 83.5 % (78.4–87.5) | 0.611 |
 PP | 96/118 | 81.3 % (73.0–87.3) | 203/244 | 83.2 % (77.9–87.3) | 0.668 |
Day 42 uncorrected ACPR | |||||
 mITT | 102/131 | 76.4 % (67.9–83.0) | 196/266 | 73.0 % (67.2–78.0) | 0.552 |
 PP | 91/118 | 77.1 % (68.4–83.7) | 176/244 | 72.1 % (66.0–77.3) | 0.377 |
Day 28 reinfection | |||||
 mITT | 23/131 | 18.7 % (12.8–26.8) | 39/266 | 15.2 % (11.3–20.1) | 0.374 |
 PP | 22/118 | 18.6 % (12.7–26.9) | 37/244 | 15.3 % (11.4–20.5) | 0.412 |
Day 42 reinfection | |||||
 mITT | 29/131 | 23.6 % (17.0–32.1) | 65/266 | 25.4 % (20.5–31.2) | 0.811 |
 PP | 27/118 | 22.9 % (16.3–31.6) | 63/244 | 26.2 % (21.1–32.3) | 0.600 |